<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://acquirersmultiple.com/2026/11/untitled-13/</loc>
    <news:news>
      <news:publication><news:name>The Acquirer&apos;s Multiple</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-11-15T20:04:51.000Z</news:publication_date>
      <news:title>The 10 Cheapest Large-Cap Stocks This Week</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://acquirersmultiple.com/2026/11/value-options/</loc>
    <news:news>
      <news:publication><news:name>The Acquirer&apos;s Multiple</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-11-15T20:04:22.000Z</news:publication_date>
      <news:title>Value Options: The AI Singularity Is Coming. This $400 Stock Is Still Mispriced?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://acquirersmultiple.com/2026/11/value-after-hours-s08-e18-2/</loc>
    <news:news>
      <news:publication><news:name>The Acquirer&apos;s Multiple</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-11-15T20:03:52.000Z</news:publication_date>
      <news:title>VALUE: After Hours (S08 E38): The Quality Growth Playbook for Biotech | David Ferreiro</news:title>
    </news:news>
  </url>
</urlset>
